Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer and Outcomes Based on COX-2 Expression and ER Status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial
J. Clin. Oncol 2019 Jan 31;[EPub Ahead of Print], AS Hamy, S Tury, X Wang, J Gao, JY Pierga, S Giacchetti, E Brain, B Pistilli, M Marty, M Espié, G Benchimol, E Laas, M Laé, B Asselain, B Aouchiche, M Edelman, F ReyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.